Two-year surveillance on fluconazole susceptibility of Candida spp isolates in a general and university hospital in Rome

Diagnostic Microbiology and Infectious Disease

Volumn 41, Issue 1-2, 2001, Pages 23-27

  Piero Testore, Gian ^a   Falco, Fulvio ^a,b   Sarrecchia, Cesare ^a   Sordillo, Pasquale ^a   Bontempo, Gilda ^a   Andreoni, Massimo ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b S EUGENIO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA RUGOSA; CANDIDA TROPICALIS; CANDIDIASIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG SENSITIVITY; HUMAN; INFECTION PREVENTION; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MYCOSIS; NONHUMAN; PRIORITY JOURNAL; WARD; YEAST;

ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; DRUG RESISTANCE, FUNGAL; FLUCONAZOLE; HOSPITALS, GENERAL; HOSPITALS, UNIVERSITY; HUMANS; ITALY; MICROBIAL SENSITIVITY TESTS;

EID: 0034772916     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(01)00280-2     Document Type: Article

References (20)

1. Emergence of Candida krusei infections after therapy of oropharyngeal candidiasis with fluconazole
2. Correlation of in vitro fluconazole susceptibility with clinical outcome for severely ill patients with oropharyngeal candidiasis
3. Fluconazole disk diffusion procedure for determining susceptibility of Candida species
4. Trends in antifungal use and epidemiology of nosocomial yeast infections in a university hospital
5. Fluconazole-resistant Candida albicans
6. Comparison of relative susceptibilities of Candida species to three antifungal agents as determined by unstandardized methods
7. Impact of fluconazole prophylaxis on fungal colonization and infection rates in neutropenic patients. The Canadian Fluconazole Study
8. Fluconazole disk diffusion susceptibility testing of Candida species
9. Declining rates of oropharyngeal candidiasis and carriage of Candida albicans associated with trends toward reduced rates of carriage of fluconazole-resistant C. albicans in human immunodeficiency virus-infected patients
10. A global evaluation of Candida species to fluconazo1e by disk diffusion
11. Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998
12. Commercial systems for fluconazole susceptibility testing of yeast: Comparison with the broth micro dilution method
13. Clinical evaluation and microbiology of oropharyngeal infection due to: Fluconazole-resistant Candida in human immunodeficiency virus-infected patients
14. Resistance of Candida species to fluconazole
15. Susceptibility of Candida spp to fluconazole. A global evaluation
16. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance
17. Infection due to resistant Candida species in patients with cancer who are receiving chemotherapy
18. High-Frequency in vitro reversible switching of Candida lusitaniae clinical isolates from amphotericin B susceptibility to resistance